Marshall Wace’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-112,051
| Closed | -$880K | – | 2913 |
|
|
2025
Q1 | $880K | Buy |
+112,051
| New | +$880K | ﹤0.01% | 1738 |
|
|
2023
Q1 | – | Sell |
-10,896
| Closed | -$225K | – | 2520 |
|
|
2022
Q4 | $225K | Sell |
10,896
-6,888
| -39% | -$142K | ﹤0.01% | 2079 |
|
|
2022
Q3 | $466K | Sell |
17,784
-210,463
| -92% | -$5.51M | ﹤0.01% | 2072 |
|
|
2022
Q2 | $5.78M | Buy |
228,247
+49,682
| +28% | +$1.26M | 0.01% | 1120 |
|
|
2022
Q1 | $5.64M | Buy |
+178,565
| New | +$5.64M | 0.01% | 1155 |
|
|
2021
Q2 | – | Sell |
-137,283
| Closed | -$3.86M | – | 2468 |
|
|
2021
Q1 | $3.86M | Sell |
137,283
-26,363
| -16% | -$740K | 0.02% | 879 |
|
|
2020
Q4 | $4.25M | Buy |
+163,646
| New | +$4.25M | 0.02% | 577 |
|
|
2020
Q2 | – | Sell |
-2,549
| Closed | -$35K | – | 1842 |
|
|
2020
Q1 | $35K | Buy |
+2,549
| New | +$35K | ﹤0.01% | 1460 |
|
|
2019
Q1 | – | Sell |
-23,065
| Closed | -$249K | – | 1991 |
|
|
2018
Q4 | $249K | Buy |
23,065
+5,342
| +30% | +$57.7K | ﹤0.01% | 1243 |
|
|
2018
Q3 | $247K | Buy |
+17,723
| New | +$247K | ﹤0.01% | 1034 |
|